In gastric cancer cells, sanguinarine was found to down-regulate miR-96-5p and miR-29c-3p and subsequently increase MAP4K4, a target gene of both miRNAs, with downstream activation of MAPK/JNK pathway and decreased tumor proliferation (Dong et al., 2019). The gene discussed is MAPK8; the disease is neoplasm.